Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 6,613-6,624 of 10,592
Drug study icon
CompletedNCT00223509

Lamictal As Add on Treatment in Mixed States of Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In United States
BipolarityDrugFrom 13 Years to 75 Years
Countries
United States
Sponsor
The University of Texas Health Science Center at San Antonio
Condition
Bipolarity
Drug study icon
CompletedNCT00723450

Lamictal as Add-on Treatment for Bipolarity type I in Pediatric Patients

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.

Remote / online
BipolarityDrugFrom 10 Years to 17 Years
Countries
United States
Sponsor
GlaxoSmithKline
Condition
Bipolarity
Drug study icon
CompletedNCT00621842

Lamotrigine for Symptoms of Geriatric Depression in bipolarity

This study exists to improve how questionnaires and follow-up reports can help identify, measure, or follow care over time. Researchers are trying to understand what questionnaires and follow-up reports could change in day-to-day care and decision-making.

In United States
Bipolarity, DepressionDrugOver 60 Years
Countries
United States
Sponsor
University Hospitals Cleveland Medical Center
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00238576

Lamotrigine in the Treatment of Bipolarity in Women of Reproductive Age

This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.

In United States
BipolarityOtherFrom 18 Years to 45 Years
Countries
United States
Sponsor
Stanford University
Condition
Bipolarity
Drug study icon
CompletedNCT00176228

Lamotrigine Monotherapy in Pediatric Bipolarity

This study exists to understand whether a therapy or guided support program is both safe enough and useful enough to take further. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In United States
BipolarityDrugFrom 10 Years to 20 Years
Countries
United States
Sponsor
University of Illinois at Chicago
Condition
Bipolarity
Drug study icon
CompletedNCT00720473

Lamotrigine Therapy in Geriatric Depression in bipolarity

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can better support energy, concentration, and everyday functioning.

In United States
Bipolarity, DepressionDrugOver 60 Years
Countries
United States
Sponsor
Mclean Hospital
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT01146002

Language-based Learning Skills and Attention Deficit Hyperactivity Disorder (ADHD): Impact of Treatment With Sustained-release Guanfacine

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

Remote / online
ADHDDrugFrom 6 Years to 12 Years
Countries
United States
Sponsor
Neurology Group of Bergen County, P.A.
Condition
ADHD
Behavioral study icon
CompletedNCT04933708

LaPPS: Labor Podcast for Patient Satisfaction

This summary needs review. Please check the official study record and contact the research team for details.

In United States
DepressionBehavioralFrom 18 Years to 50 Years
Countries
United States
Sponsor
University of Pennsylvania
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.